Parnaparin
- Generic Name
- Parnaparin
- Drug Type
- Small Molecule
- CAS Number
- 9005-49-6
- Unique Ingredient Identifier
- U6K360XMIU
- Background
Parnaparin is an heparin of low molecular weight with antithrombotic effects.
- Indication
Used in the prevention and treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism) and in the treatment of myocardial infarction.
- Associated Conditions
- Deep Vein Thrombosis
Weight Adjusted Low Molecular Weight Heparin in Recurrent Implantation Failure: a Randomized Open Labeled Trial
Phase 3
Terminated
- Conditions
- InfertilityLow Molecular Weight Heparin
- Interventions
- First Posted Date
- 2016-12-14
- Last Posted Date
- 2016-12-14
- Lead Sponsor
- Istituto Clinico Humanitas
- Target Recruit Count
- 271
- Registration Number
- NCT02991950
Parnaparin vs Aspirin in the Treatment of Retinal Vein Occlusion
- First Posted Date
- 2008-08-12
- Last Posted Date
- 2008-08-12
- Lead Sponsor
- Università degli Studi dell'Insubria
- Target Recruit Count
- 67
- Registration Number
- NCT00732927
- Locations
- 🇮🇹
University Of Insubria, Varese, Italy
Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein Thrombosis
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2021-03-19
- Target Recruit Count
- 664
- Registration Number
- NCT00362947
- Locations
- 🇮🇹
Dept. Angiology & Blood Coagulation; University Hospital S.Orsola-Malpighi, Bologna, BO, Italy
🇮🇹U.O. Medicina Critica, Piacenza, PC, Italy
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath